Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cannabinoids and Cytochrome P450 Interactions
Ondřej Zendulka, Gabriela Dovrtělová, Kristýna Nosková, et al.
Current Drug Metabolism (2016) Vol. 17, Iss. 3, pp. 206-226
Closed Access | Times Cited: 244

Showing 1-25 of 244 citing articles:

Practical considerations in medical cannabis administration and dosing
Caroline A. MacCallum, Ethan B. Russo
European Journal of Internal Medicine (2018) Vol. 49, pp. 12-19
Closed Access | Times Cited: 554
The pharmacokinetics and the pharmacodynamics of cannabinoids
Catherine Lucas, Peter Galettis, Jennifer Schneider
British Journal of Clinical Pharmacology (2018) Vol. 84, Iss. 11, pp. 2477-2482
Open Access | Times Cited: 552
A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects
Lesley Taylor, Barry E. Gidal, Graham Blakey, et al.
CNS Drugs (2018) Vol. 32, Iss. 11, pp. 1053-1067
Open Access | Times Cited: 370
Interactions between cannabidiol and commonly used antiepileptic drugs
Tyler E. Gaston, E. Martina Bebin, Gary Cutter, et al.
Epilepsia (2017) Vol. 58, Iss. 9, pp. 1586-1592
Open Access | Times Cited: 312
Cannabinoids in the Treatment of Epilepsy: Hard Evidence at Last?
Emilio Perucca
Journal of Epilepsy Research (2017) Vol. 7, Iss. 2, pp. 61-76
Open Access | Times Cited: 208
A systematic review of cannabidiol dosing in clinical populations
Sophie Millar, Nicole L. Stone, Z.D. Bellman, et al.
British Journal of Clinical Pharmacology (2019) Vol. 85, Iss. 9, pp. 1888-1900
Open Access | Times Cited: 197
Pharmacology of cannabinoids in the treatment of epilepsy
Tyler E. Gaston, Daniel Friedman
Epilepsy & Behavior (2017) Vol. 70, pp. 313-318
Closed Access | Times Cited: 185
Towards Better Delivery of Cannabidiol (CBD)
Sophie Millar, Ryan Maguire, Andrew Yates, et al.
Pharmaceuticals (2020) Vol. 13, Iss. 9, pp. 219-219
Open Access | Times Cited: 172
Cannabis and Its Secondary Metabolites: Their Use as Therapeutic Drugs, Toxicological Aspects, and Analytical Determination
Joana Gonçalves, Tiago Rosado, Sofia Soares, et al.
Medicines (2019) Vol. 6, Iss. 1, pp. 31-31
Open Access | Times Cited: 159
Pharmacological and Therapeutic Properties of Cannabidiol for Epilepsy
Valentina Franco, Emilio Perucca
Drugs (2019) Vol. 79, Iss. 13, pp. 1435-1454
Closed Access | Times Cited: 145
ASRA Pain Medicine consensus guidelines on the management of the perioperative patient on cannabis and cannabinoids
Shalini Shah, Eric S. Schwenk, Rakesh V. Sondekoppam, et al.
Regional Anesthesia & Pain Medicine (2023) Vol. 48, Iss. 3, pp. 97-117
Open Access | Times Cited: 57
Hypothesized pharmacogenomic and medication influences on tetrahydrocannabinol and cannabidiol metabolism in a cohort of unselected oral cannabis users
Jessica Wright, Linda Huang, Basant E. Katamesh, et al.
Journal of Cannabis Research (2025) Vol. 7, Iss. 1
Open Access | Times Cited: 2
Medicinal Cannabis—Potential Drug Interactions
Indeewarie Hemamali Dissanayake, Chun Guang Li
Medicines (2018) Vol. 6, Iss. 1, pp. 3-3
Open Access | Times Cited: 149
Randomized blinded controlled clinical trial to assess the effect of oral cannabidiol administration in addition to conventional antiepileptic treatment on seizure frequency in dogs with intractable idiopathic epilepsy
Stephanie McGrath, Lisa R. Bartner, Sangeeta Rao, et al.
Journal of the American Veterinary Medical Association (2019) Vol. 254, Iss. 11, pp. 1301-1308
Closed Access | Times Cited: 142
Critical Aspects Affecting Cannabidiol Oral Bioavailability and Metabolic Elimination, and Related Clinical Implications
Emilio Perucca, Meir Bialer
CNS Drugs (2020) Vol. 34, Iss. 8, pp. 795-800
Closed Access | Times Cited: 124
The Genomics ofCannabisand Its Close Relatives
Igor Kovalchuk, Marco Pellino, Philippe Rigault, et al.
Annual Review of Plant Biology (2020) Vol. 71, Iss. 1, pp. 713-739
Closed Access | Times Cited: 123
Targeting Cannabinoid Signaling in the Immune System: “High”-ly Exciting Questions, Possibilities, and Challenges
Attila Oláh, Zoltán Szekanecz, Tamás Bı́ró
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 118
Cannabidiol—from Plant to Human Body: A Promising Bioactive Molecule with Multi-Target Effects in Cancer
Brigitta Kis, Feng Chen Ifrim, Valentina Buda, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 23, pp. 5905-5905
Open Access | Times Cited: 116
The Essential Medicinal Chemistry of Cannabidiol (CBD)
Kathryn M. Nelson, Jonathan Bisson, Gurpreet Singh, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 21, pp. 12137-12155
Open Access | Times Cited: 109
Cannabis sativa: Much more beyond Δ9-tetrahydrocannabinol
Patrícia Alves, Cristina Amaral, Natércia Teixeira, et al.
Pharmacological Research (2020) Vol. 157, pp. 104822-104822
Closed Access | Times Cited: 106
Vaporized Cannabis Extracts Have Reinforcing Properties and Support Conditioned Drug-Seeking Behavior in Rats
Timothy G. Freels, Lydia N. Baxter-Potter, Janelle M. Lugo, et al.
Journal of Neuroscience (2020) Vol. 40, Iss. 9, pp. 1897-1908
Open Access | Times Cited: 103
Interaction between warfarin and cannabis
Per Damkier, Dorte Lassen, Mette Marie Hougaard Christensen, et al.
Basic & Clinical Pharmacology & Toxicology (2018) Vol. 124, Iss. 1, pp. 28-31
Open Access | Times Cited: 97
Sex differences and the endocannabinoid system in pain
Henry Blanton, Robert C. Barnes, Melissa C. McHann, et al.
Pharmacology Biochemistry and Behavior (2021) Vol. 202, pp. 173107-173107
Open Access | Times Cited: 97
Cannabidiol as a Therapeutic Target: Evidence of its Neuroprotective and Neuromodulatory Function in Parkinson’s Disease
Felipe Patricio, Alan Axel Morales-Andrade, Aleidy Patricio-Martínez, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 96
The Interplay between the Endocannabinoid System, Epilepsy and Cannabinoids
Keith Cheung, Hassendrini N. Peiris, Geoff Wallace, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 23, pp. 6079-6079
Open Access | Times Cited: 91
Page 1 - Next Page

Scroll to top